Philip Morris Misr announces its new price list for all variants of its conventional cigarettes products ‘Merit, Marlboro and L&M’.
Philip Morris Misr assures all its adult smokers and nicotine users that the new prices are transparently announced on product packaging through the QR code that was implemented on conventional cigarettes and heated tobacco packs since 2022.
Ali Nevzat Karman, Managing Director of Philip Morris Egypt and Levant, said: “Philip Morris Misr continues to work hard to meet the needs of adult smokers and nicotine users in the Egyptian market and support the company’s ambitious vision of a smoke-free future.”
Philip Morris Misr’s new price list is as follows:
• All variants of Merit will be sold officially at EGP 90 per pack.
• All variants of Marlboro will be sold officially at EGP 84 per pack.
• All variants of Marlboro Crafted will be sold officially at EGP 74 per pack.
• All variants of L&M will be sold officially at EGP 64 per pack.
• All variants of HEETS Selections will be sold officially at EGP 64 per pack.
• All variants of HEETS Dimensions will be sold officially at EGP 64 per pack.
• All variants of TEREA will be sold officially at EGP 64 per pack.
The company calls upon retailers and distributors to conform to the declared prices.
**
Philip Morris International: Delivering a Smoke-Free Future
Philip Morris International (PMI) is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products.
Since 2008, PMI has invested $12.5 billion to develop, scientifically substantiate, and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies’ IQOS and ZYN brands. The U.S. Food and Drug Administration has authorized versions of PMI’s IQOS Platform 1 devices and consumables and Swedish Match’s General snus as Modified Risk Tobacco Products. As of December 31, 2023, PMI’s smoke-free products were available for sale in 84 markets, and PMI estimates that approximately 20.8 million adults around the world had already switched to IQOS and stopped smoking. Smoke-free products accounted for approximately 37% of PMI’s total full-year 2023 net revenues. With a strong foundation and significant expertise in life sciences, PMI announced in February 2021 its ambition to expand into wellness and healthcare areas and, through its Vectura Fertin Pharma business, aims to enhance life through the delivery of seamless health experiences. For more information, please visit www.pmi.com and www.pmiscience.com